Serving To Educate Primary Care Clinicians On Metabolic Issues
Home
Subscribe
Feedback
Contact Us
Evidence Based Medicine
Medical Education
Metabolic Diseases
About Us
PCMG CME
PCMG Non-CME
Resources
Needs Survey
Commentaries
Survey
HBP Webinar Post Survey
I am a(n)…
[ Required ]
Select...
MD/DO
NP/RN
PA
Other
How many years have you been in practice?
[ Required ]
Select...
1-5
6-10
11-15
16-20
Over 20
What is your practice setting?
[ Required ]
Select...
Solo Practice
Group Practice
Hospital
Clinic
Academic
Other
Number of patients seen per month with hypertension
[ Required ]
Select...
1-10
11-20
21-30
31-40
41-50
Over 50
Please rate the following:
Degree to which your educational expectations were met
[ Required ]
Select...
Excellent
Above Average
Average
Fair
Poor
Relevance to your practice
[ Required ]
Select...
Excellent
Above Average
Average
Fair
Poor
Effective faculty presenter
[ Required ]
Select...
Excellent
Above Average
Average
Fair
Poor
Overall Presentation
[ Required ]
Select...
Excellent
Above Average
Average
Fair
Poor
Please rate the degree to which the Learning Objectives were met.
Describe the key pathophysiologic mechanisms by which hypercortisolism contributes to HTN and associated cardiometabolic risks.
[ Required ]
Select...
Completely
Mostly
Somewhat
Not at all
Identify clinical features and risk factors that should prompt evaluation for hypercortisolism in patients presenting with resistant HTN.
[ Required ]
Select...
Completely
Mostly
Somewhat
Not at all
Apply recommended screening methods and diagnostic pathways for suspected hypercortisolism in patients with HTN, including test selection, interpretation, and criteria for specialty referral.
[ Required ]
Select...
Completely
Mostly
Somewhat
Not at all
Agree or Disagree?
The presentation was fair and balanced, free of commercial bias.
[ Required ]
Select...
YES
NO
I feel more competent as a result of the presentation.
[ Required ]
Select...
YES
NO
The presentation was scientifically rigorous.
[ Required ]
Select...
YES
NO
The content contributed valuable information that will assist in improving patient outcomes
[ Required ]
Select...
Strongly Agree
Agree
Unsure
Disagree
Strongly Disagree
My participation in this activity will improve the efficacy of the healthcare team.
[ Required ]
Select...
Strongly Agree
Agree
Unsure
Disagree
Strongly Disagree
Will you change your practice behaviors as a result of the presentation?
[ Required ]
Select...
Absolutely
Probably
Unsure
Unlikely
No
What will you change?
[ Required ]
Recognize the high prevalence of hypercortisolism in HTN
Consider hypercortisolism in the differential diagnosis in at-risk patients with HTN
Identify at-risk patients with clinical characteristics suggestive of hypercortisolism
Use the 1-mg DST as the preferred first-line screening test for hypercortisolism
Refer patients as needed while optimizing BP and cardiometabolic risk management
Educate my patients
Other
If Other
Because you are likely to make changes to your practice behaviors, you are eligible to qualify for T2P (Translation to Practice) Credit, an additional 2.0 Credits. Please provide your email address below and we will send you a link to a followup survey in six weeks. If you have made changes to your practice behaviors, you will receive those additional two credits.
[ Invalid e-mail address ]
What barriers to change do you foresee?
[ Required ]
Cost
Insurance Coverage
Formulary
Patient Compliance
Time with Patient
Other
None
If Other
What was your level of knowledge on this subject?
Before the presentation
[ Required ]
Select...
None
Little
Some
Considerable
Expert
After the presentation
[ Required ]
Select...
None
Little
Some
Considerable
Expert
The approximate prevalence of hypercortisolism in adults with resistant HTN is 7.1%
[ Required ]
Adrenal nodules are found in ~35.3% of patients with resistant HTN and hypercortisolism
Adrenal nodules are found in ~72.7% of patients with resistant HTN and hypercortisolism
The approximate prevalence of hypercortisolism in adults with resistant HTN is 7.1%
The approximate prevalence of hypercortisolism in adults with resistant HTN is 27.3%
Which of the following is the most sensitive test for identifying hypercortisolism in patients with HTN?
[ Required ]
1-mg dexamethasone suppression test (DST)
24-hour urine free cortisol (UFC)
Late-night salivary cortisol (LNSC)
Plasma adrenocorticotropic hormone (ACTH)
How confident do you feel in your answer to the previous question?
[ Required ]
Select...
Very confident
Confident
Somewhat confident
Not confident
What do you need to learn more about on this topic?
Submit